https://www.selleckchem.com/pr....oducts/Trichostatin-
s (≥75), when compared to younger patients (55 years), again the difference is well below the MCID and is clinically insignificant. Although there are statistically significant differences in pain relief, functional improvement, and quality of life between younger and older patients among different patients' age groups, there is no clinically significant difference. THA provides an improvement in quality of life by decreasing pain and increasing function in all 4 age groups, with large improvements in Patient-Reported Outcome
Like
Comment
Share
